Unknown

Dataset Information

0

Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D.


ABSTRACT: Mycobacterium abscessus (MAB) is a species of nontuberculous mycobacteria (NTM) and a major causative pathogen of pulmonary diseases especially in patients with cystic fibrosis. MAB infection is notoriously difficult to treat because of its intrinsic or inducible resistance to most antibiotics. The rough (R) morphotype of MAB, lacking cell surface glycopeptidolipids (GPLs), is associated with more severe and persistent infection than the smooth (S) type; however, the mechanisms underlying the R type's virulence and the relation with GPLs remain unclear. In this study, we found that R-type MAB is much more proapoptotic than the S type, as a result of GPL-mediated inhibition of macrophage apoptosis. Polar GPLs inhibited an apoptotic response (induced by proapoptotic stimuli) by suppressing ROS production and the cytochrome c release and by preserving mitochondrial transmembrane potential. Furthermore, GPLs were found to be targeted to mitochondria and interacted with cyclophilin D; their acetylation was essential for this interaction. Finally, GPLs inhibited the intracellular growth and bacterial spreading of R-type MAB among macrophages via apoptosis inhibition. These findings suggest that GPLs limit MAB virulence by inhibiting apoptosis and the spread of bacteria and therefore provide a novel insight into the mechanism underlying virulence of MAB.

SUBMITTER: Whang J 

PROVIDER: S-EPMC5596598 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D.

Whang Jake J   Back Yong Woo YW   Lee Kang-In KI   Fujiwara Nagatoshi N   Paik Seungwha S   Choi Chul Hee CH   Park Jeong-Kyu JK   Kim Hwa-Jung HJ  

Cell death & disease 20170824 8


Mycobacterium abscessus (MAB) is a species of nontuberculous mycobacteria (NTM) and a major causative pathogen of pulmonary diseases especially in patients with cystic fibrosis. MAB infection is notoriously difficult to treat because of its intrinsic or inducible resistance to most antibiotics. The rough (R) morphotype of MAB, lacking cell surface glycopeptidolipids (GPLs), is associated with more severe and persistent infection than the smooth (S) type; however, the mechanisms underlying the R  ...[more]

Similar Datasets

| S-EPMC7650608 | biostudies-literature
| S-EPMC5399554 | biostudies-literature
| S-EPMC5129020 | biostudies-literature
| S-EPMC4694086 | biostudies-other
| S-EPMC3911466 | biostudies-literature
| S-EPMC3878664 | biostudies-literature
| S-EPMC3564728 | biostudies-literature
| S-EPMC8370238 | biostudies-literature
| S-EPMC5503620 | biostudies-literature
| S-EPMC3577976 | biostudies-other